
San Raffaele Telethon Institute for Gene Therapy
3D genome dynamics in differentiation and disease

In our lab, we are interested in understanding the mechanisms of enhancer-promoter interactions (EPIs), the mechanisms by which chromatin regulators regulate EPIs, how these biophysical processes are dysregulated after mutations of chromatin regulators, and how these processes are established and maintained during cell differentiation to develop new epigenetic therapy approaches. To study the biophysics of chromatin interactions, we combine 3D super-resolution live cell imaging, genome engineering, 3D genomics and single-cell methods, with polymer simulations and computational approaches in a complete interdisciplinary approach.
Research Activity
Mechanism of enhancer-promoter interactions - Using genome editing, it is possible to insert synthetic labels to track the 3D position of promoters, enhancers, and detect nascent RNA when corresponding binding proteins fused with fluorophores are also expressed. With this approach and advanced microscopy such as 3D super-resolution live-cell imaging, it is possible to understand the causal relationship between chromatin interactions and transcription. We will use this system to understand how EPI are regulated during neuronal differentiation. Moreover, with microscopy, we can measure the residency time of protein complexes and the mobility of the chromatin itself, contributing to understanding the biophysics of the chromatin in differentiating cells.
Mechanism of chromatin regulation - A large variety of chromatin modifications, chromatin loopers, and even transcription of enhancers are known to be involved in EPI. Some examples are the histone modification H3K27Ac, the chromatin loopers YY1 and LDB1, the cohesin motor complex, and eRNAs. However, the precise mechanism by which they participate and contribute to EPI remains unclear. Are they required to establish the interaction or to maintain it? How is this propagated in daughter cells? How long does chromatin memory persist? All of these questions, and more, can be addressed with our biophysics interdisciplinary approach.
Mutations in chromatin regulators, regulatory sequences, and EPI engineering - Mutations in chromatin regulators and regulatory sequences often occur in malignancies and can be cause of neurodevelopmental disorders. To design novel therapeutic approaches, it is first necessary to understand how mutations in regulators or regulatory regions impact the regulation mechanism. Once we identify dysregulated mechanisms or interactions, we can design synthetic ad hoc approaches to engineer EPIs and restore physiological expression levels.
Pereira MF, Finazzi V, Rizzuti L, Aprile D, Aiello V, Mollica L, Riva M, Soriani C, Dossena F, Shyti R, Castaldi D, Tenderini E, Carminho-Rodrigues MT, Bally JF, de Vries BBA, Gabriele M*, Vitriolo A*, Testa G*YY1 mutations disrupt corticogenesis through a cell type specific rewiring of cell-autonomous and non-cell-autonomous transcriptional programs. Mol Psychiatry. 2025; *co-last authors
Jusuf JM, Grosse-Holz S, Gabriele M, Mach P, Flyamer IM, Zechner C, et al. Genome-wide absolute quantification of chromatin looping. bioRxiv; 2025
Gabriele M, Brandão HB, Grosse-Holz S, Jha A, Dailey GM, Cattoglio C, et al. Dynamics of CTCF- and cohesin-mediated chromatin looping revealed by live-cell imaging. Science. 2022;376:496–501.
Linda K, Lewerissa EI, Verboven AHA, Gabriele M, Frega M, Klein Gunnewiek TM, et al. Imbalanced autophagy causes synaptic deficits in a human model for neurodevelopmental disorders. Autophagy. 2021;1–20.
Brandão HB*, Gabriele M*, Hansen AS. Tracking and interpreting long-range chromatin interactions with super-resolution live-cell imaging. Curr Opin Cell Biol. 2020;70:18–26. *Co-first author
Gabriele M*, Hansen S A, Testa G. Molecular mechanisms of YY1 overexpression in human cancers and its prognostic significance. 2020. page 124–71. *corresponding author
Gabriele M, Lopez Tobon A, D’Agostino G, Testa G. The chromatin basis of neurodevelopmental disorders: Rethinking dysfunction along the molecular and temporal axes. Prog Neuropsychopharmacol Biol Psychiatry. 2018;84:306–27.
Nabais Sá MJ, Gabriele M, Testa G, de Vries BB. Gabriele-de Vries Syndrome. GeneReviews®. 2019
Gabriele M, Vulto-van Silfhout AT, Germain P-L, Vitriolo A, Kumar R, Douglas E, et al. YY1 Haploinsufficiency Causes an Intellectual Disability Syndrome Featuring Transcriptional and Chromatin Dysfunction. Am J Hum Genet. 2017;100:907–25.